Parent firm Sanofi is a publicly-traded company that posted 2017 net income of $10 billion on sales of nearly $43.5 billion. Its shares closed Wednesday at $37.63, up 83 cents, on the New York Stock Exchange.
SNY), succeeded in the clinic. Unfortunately, commercial launches that take baby steps when investors expect giant leaps can pressure even a biotech's stock price no matter how productive its discovery engine may be. The past …
This is a good time to see how well, or how poorly, the company’s stock holdings have performed so far this year. If you haven’t already done so, …
MarketWatch · 18d
Regeneron Pharmaceuticals Inc and Sanofi SA will slash the price of their expensive cholesterol drug for Express Scripts Holdings Co customers in exchange for greater patient access, with some savings to be shared with consumers, the companies said on Tuesday.
Reuters · 21d
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when ...
Yahoo Finance · 2mon
Bioverativ common stock will cease to be traded on the NASDAQ Stock Market. Lazard acted as exclusive financial advisor to Sanofi. Guggenheim Securities and J.P. Morgan Securities LLC acted as financial advisors to Bioverativ. Weil, Gotshal & Manges LLP ...
GlobeNewswire · 2mon
(ShareCast News) - Global investor Advent International has entered into exclusive negotiations with French pharmaceutical group Sanofi about the acquisition of its European generics business, Zentiva, for €1.9bn. Advent's offer is firm, binding and ...